STAT3 and triple-negative breast carcinoma: The literature has indicated that ENSA expression is significantly increased in triple-negative breast cancer, where it activates signal transducer and activator of transcription 3 (STAT3) to regulate cholesterol biosynthesis, thus promoting tumor progression.[32] STAT3 acts as a convergence point for various oncogenic signaling pathways and has been linked with AS.